JIA, treatment and possible risk of malignancies

Research output: Contribution to journalArticlepeer-review


The effect of biological therapies on cancer risk in Jia is controversial owing to confounding factors such as the use of concomitant immunosuppressants. a study has shed new light on this association, but questions still remain on the effect of the disease itself and biological therapies on cancer risk.

Original languageEnglish
Pages (from-to)6-7
Number of pages2
JournalNature Reviews Rheumatology
Issue number1
Publication statusPublished - Jan 2011

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'JIA, treatment and possible risk of malignancies'. Together they form a unique fingerprint.

Cite this